1-(aminomethyl)benzosuberane | 57421-34-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-(aminomethyl)benzosuberane
• 英文别名: 3-Aminomethyl-1:2-benzocyclohepten-(1)；6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ylmethanamine
• CAS: 57421-34-8
• 化学式: C₁₂H₁₇N
• 分子量: 175.274
• InChiKey: IGLSDLDKYJAVQW-UHFFFAOYSA-N

物化性质

• 沸点：
  162-163 °C(Press: 12 Torr)
• 密度：
  0.980±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(aminomethyl)benzosuberane 以96%的产率得到
  参考文献：
  名称：

  VEJDELEK Z. J.; DLABAC A.; KAKAC B.; PROTIVA M., COLLECT. CZECH. CHEM. COMMUNS , 1975, 40, NO 5, 1625-1628

  摘要：

  DOI：
• 作为产物：
  描述：

  6,7,8,9-tetrahydro-5H-benzo[7]annulene-5-carbaldehyde 在 镍 氨 、 氢气 作用下， 以 乙醇 为溶剂， 生成 1-(aminomethyl)benzosuberane
  参考文献：
  名称：

  Umsetzungen der 1：2-benzocyclenyl-3-methylamine mit salpetrigersäure

  摘要：

  [1：2-苯并环烯基-3-甲基]-重氮离子在乙酸中的分解产生3-羟甲基-1：2-苯并环戊烯-1（IV）的乙酸酯以及环扩大的3-和4-羟基-1：2-苯并环戊酮-1（VIII和VI）。这些产物的比例在很大程度上取决于环的尺寸。伯碳鎓离子XI似乎可以作为第一中间体。讨论了对芳基和烷基迁移程度的构象控制。

  DOI：

  10.1016/s0040-4020(01)98625-9

文献信息

• Direct Access to Primary Amines from Alkenes by Selective Metal‐Free Hydroamination
  作者：Yi‐Dan Du、Bi‐Hong Chen、Wei Shu

  DOI：10.1002/anie.202016679

  日期：2021.4.26

  selective synthesis of primary amines from easily available precursors is attractive yet challenging. Herein, we report the rapid synthesis of primary amines from alkenes via metal‐free regioselective hydroamination at room temperature. Ammonium carbonate was used as ammonia surrogate for the first time, allowing for efficient conversion of terminal and internal alkenes into linear, α‐branched, and α‐tertiary

  由容易获得的前体直接和选择性合成伯胺是有吸引力的，但仍具有挑战性。在此，我们报道了室温下通过无金属的区域选择性加氢胺从烯烃快速合成伯胺的方法。碳酸铵首次用作氨替代物，可在温和条件下将末端和内部烯烃有效转化为线性，α支化和α叔伯胺。该方法提供了一种直接而有效的方法，可用于制药化学和其他领域特别感兴趣的各种先进的，高度官能化的伯胺。
• SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE
  申请人：Shionogi & Co., Ltd.

  公开号：EP2412708A1

  公开（公告）日：2012-02-01

  This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.

  本发明提供了具有抗病毒活性，特别是对流感病毒有抑制活性的化合物，更优选提供了具有帽依赖性内切酶抑制活性的取代 3-羟基-4-吡啶酮衍生物。
• New Purines and Purine Analogs as Modulators of Multidrug Resistance
  作者：Alain Dhainaut、Gilbert Regnier、Andre Tizot、Alain Pierre、Stephane Leonce、Nicolas Guilbaud、Laurence Kraus-Berthier、Ghanem Atassi

  DOI：10.1021/jm960361i

  日期：1996.1.1

  A series of 36 purine and purine analog derivatives have been synthesized and tested for their ability to modulate multidrug resistance in vitro (P388/VCR-20 and KB-A1 cells) and in vivo (P388/VCR leukemia). Compounds were compared to S9788, a triazine derivative which has already shown some activity during phase 1 clinical trials and also a limiting cardiovascular side effect possibly linked to its calcium channel affinity. The fact that active compounds increase adriamycin accumulation in the resistant KB-A1 cells, and not in the sensitive KB-3-1 cells, suggests they act predominantly by inhibiting the P-glycoprotein-catalyzed efflux of cytotoxic agents. No direct relation was found between the affinity for the phenylalkylamine binding site of the calcium channel and in vitro sensitization of resistant cells. In vivo, when administered po in association with vincristine (0.25 mg/kg), five compounds (3, 4, 9, 25, and 26), of very differing calcium channel affinities (K-i from 5 to 560 nM), fully restored (T/V greater than or equal to 1.4) the sensitivity of P388/VCR leukemia to vincristine.
• N6-Substituted adenosine receptor agonists: potential antihypertensive agents
  作者：B. K. Trivedi、C. J. Blankley、J. A. Bristol、H. W. Hamilton、W. C. Patt、W. J. Kramer、S. A. Johnson、R. F. Bruns、D. M. Cohen、M. J. Ryan

  DOI：10.1021/jm00107a025

  日期：1991.3

  Adenosine is known to exert a wide range of pharmacological effects including hypotension. This effect of adenosine suggested that modified analogues of adenosine might provide useful antihypertensive agents. Thus, we prepared a series of novel N6-benzocycloalkyladenosines and studied their receptor binding and antihypertensive activity. The structure-activity relationship study shows that the adenosine analogues having the hydrophobic phenyl moiety one carbon away from the C6-nitrogen have modest affinity and selectivity for the A1 receptor, whereas those with the phenyl moiety two carbons away from the C6-nitrogen have excellent affinity and selectivity for the A1 receptor. Many of these analogues showed excellent antihypertensive activity with a wide range of effects on heart rate. There is no direct correlation between the receptor binding affinities and antihypertensive activity; however, it is more closely associated with A1 than A2 affinity. The bradycardic effect of these agonists seems to be due to the A1 affinity. From this set, compound 3 was further evaluated in secondary antihypertensive screens. It lowered the blood pressure dose dependently with effects lasting for over 20 h following administration of a 30 mg/kg dose. Compound 3 was also effective in lowering blood pressure in a renal hypertensive rat model. Thus, appropriately modified N6-substituted adenosines represent a novel class of antihypertensive agents.
• TRIVEDI, B. K.;BLANKLEY, C. J.;BRISTOL, J. A.;HAMILTON, H. W.;PATT, W. C.+, J. MED. CHEM., 34,(1991) N, C. 1043-1049
  作者：TRIVEDI, B. K.、BLANKLEY, C. J.、BRISTOL, J. A.、HAMILTON, H. W.、PATT, W. C.+

  DOI：——

  日期：——